BCL2 and colorectal carcinoma: The current study focused on developing 3D ORC models for CRC by utilizing PDXs that exhibited high expression of BCL-2 family proteins (ORC-82) to evaluate the usefulness of these models in assessing the efficacy of ABT-263.